XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses        
Research and development $ 10,328 $ 3,112 $ 22,132 $ 8,115
General and administrative 6,478 1,507 17,804 4,084
Total operating expenses 16,806 4,619 39,936 12,199
Net operating loss (16,806) (4,619) (39,936) (12,199)
Interest income 1,017 665 2,901 887
Interest expense   (7)   (24)
Other income (expense), net (15) (0) (24)  
Net loss $ (15,804) $ (3,961) $ (37,059) $ (11,335)
Net loss per share, basic $ (0.4) $ (0.19) $ (0.96) $ (1.37)
Net loss per share, diluted $ (0.4) $ (0.19) $ (0.96) $ (1.37)
Weighted average number of common shares and prefunded warrants outstanding, basic 39,741,404 21,161,143 38,644,395 8,282,118
Weighted average number of common shares and prefunded warrants outstanding, diluted 39,741,404 21,161,143 38,644,395 8,282,118